Close Menu

Correlagen Diagnostics

New Products

Premium

Illumina cBot, Correlagen CardioGeneScan

The assay, Correlagen Diagnostics' first to run on a next-generation sequencer, will cover approximately 300 genes associated with hereditary cardiovascular disease. Going forward, the genetic testing company plans to use the Helicos system for other assays in the areas of endocrinology, neuropsychiatry, and immunology.

Correlagen, which has a CLIA-certified laboratory and is based in Waltham, Mass., plans to use the Helicos platform for new genetic tests that require resequencing "broad panels" of genes in the areas of cardiology, endocrinology, neuropsychiatry, and immunology.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.